Trial Profile
Efficacy of istradefylline, in patients with fluctuating Parkinson's disease (PD) with preserved motor functions.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2015
Price :
$35
*
At a glance
- Drugs Istradefylline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 20 Dec 2015 New trial record